Bayer sets ambitious growth and earnings aspirations
Further sales and earnings growth pursued in all businesses / Combined peak annual sales potential of recently launched pharmaceutical products raised to over EUR 10 billion / Six further product candidates in the Pharmaceuticals pipeline have combined peak sales potential of at least EUR 6 billion / Strong brands driving business at Consumer Health / Above-market sales growth and substantial margin increases expected at Crop Science following the closing of the agreed acquisition of Monsanto (Source: Bayer Company News)
Source: Bayer Company News - September 20, 2016 Category: Pharmaceuticals Source Type: news

FDA approves new five-year-contraceptive of Bayer (for specialized target groups only)
(Source: Bayer Company News)
Source: Bayer Company News - September 19, 2016 Category: Pharmaceuticals Source Type: news

Bayer and Monsanto to Create a Global Leader in Agriculture
Realizes a shared vision of integrated agricultural offerings, delivering enhanced solutions for growers and creates a leading innovation engine for the next generation of farming / USD 128 per share in all-cash transaction, represents 44 percent premium to Monsanto shareholders and an aggregate value of USD 66 billion / Significant value creation with expected annual synergies of approximately USD 1.5 billion after year three; plus additional synergies from integrated solutions in future years / Bayer shareholders expected to benefit from accretion to core EPS in the first full year after closing and double-digit percenta...
Source: Bayer Company News - September 14, 2016 Category: Pharmaceuticals Source Type: news

Bayer again listed in the Dow Jones Sustainability World Index
Bayer Board member Klusik:“Integrating sustainability into daily work routines” / Bayer listed continuously in the DJSI World since its inception in 1999 (Source: Bayer Company News)
Source: Bayer Company News - September 8, 2016 Category: Pharmaceuticals Source Type: news

Bayer ’s commitment to innovation and sustainability will help shape the future of farming
Strong innovation pipeline will help solve key agricultural challenges / Sustained high R&D investment level of about 10 percent of sales confirmed / EUR 2.5 billion capital expenditure program from 2017 to 2020 / Strong commitment to sustainability also supported by investments in Digital Farming, ForwardFarming and Smallholder Farming (Source: Bayer Company News)
Source: Bayer Company News - September 7, 2016 Category: Pharmaceuticals Source Type: news